West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc. (WST) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)
AI-generated summary
FMR LLC filed a Schedule 13G/A reporting beneficial ownership of West Pharmaceutical Services Inc. as of 09/30/2026. FMR LLC reported beneficial ownership of 5,962,737.88 shares.
Key facts
- Document
- —
More WST filings
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 26, 2026
- 4
Filed Oct 2, 2026
- 4
Filed Sep 15, 2026
- 4
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.